Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

On Wednesday, U.S. Senators Catherine Cortez Masto (D-Nev.), Amy Klobuchar (D-Minn.), and Peter Welch (D- Vt.) introduced the ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Medicare’s drug price negotiation program is progressing into its third round of selections, HHS announced last week. And as the Biden-era program moves full steam ahead, changes are in store ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The Trump administration has issued new draft guidance for the third cycle of Medicare drug price negotiations. | The Trump ...

said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...